EUVIMEDEUVIMED entdecken
Crossref

Characterization of the Chitosan Microencapsulation of Rosa damascena Mill. Extract and (Lacticaseibacillus casei and Bifidobacterium longum) Probiotics

Rias Gesang Kinanti, Rokhmatul Asiyah, Dimas Nur Ramadhani, Ardhiyanti Puspita Ratna, Sri Rahayu Lestari, Tanaporn Hengpratom, Elfi Anis Saati

Applied food biotechnology · 30.12.2025

DOI: 10.22037/afb.v12i1.46674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied food biotechnology, erschienen am 30.12.2025. Verfasst von Rias Gesang Kinanti und 6 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Rosa damascena Mill. possesses bioactive compounds, including flavonoids and anthocyanins, which are addressed for their antioxidant and anti-inflammatory characteristics. This study aimed to develop and optimize a microencapsulation system for rose extract and probiotics. It focused on particle size and morphological characteristics analyzed via particle size analysis, scanning electron microscopy-energy dispersive X-ray spectroscopy and , gas chromatography-mass spectrometry and further assessed the bioavaliability and bioaccessibility of the encapsulated probiotics. Material and Methods: Lacticaseibacillus casei and Bifidobacterium longum were cultivated in De Man, Rogosa, and Sharpe broth. The petals of Rosa damascena Mill. were extracted with ethanol 70% 1:1 aqueous solution. The microencapsulation involved dissolving the extract and probiotics, followed by the addition of chitosan and sodium tripolyphosphate to form stable colloids. The particle size was analyzed using dynamic light scattering and the morphology of microcapsules was investigated using scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy. Detection of ethanol was carried out using gas chromatography-mass spectrometry. Probiotic viability was assessed after storage at 4 °C for 0, 14 and 28 d and bioaccessibility was assessed using in vitro gastrointestinal simulation method. Results and Conclusion: The microencapsulation process resulted in spherical microcapsules with a mean particle size of 3107 nm ±273.2. Scanning electron microscopy analysis verified uniform morphology, indicating effective encapsulation. The probiotic count for microencapsulated samples was 5.16 ±0.37 log cfu ml-1. Gas chromatography-mass spectrometry data showed that the ethanol content was 2.53% ±0.21 (v/v). Microencapsulation of R. damascena Mill. and the probiotics increased the recovery of anthocyanin by 9%. These findings have suggested that combining microencapsulation with probiotic strains provides viable strategy to improve the functional delivery of anthocyanin-rich botanicals in nutraceutical uses. Keywords: Microencapsulation, Rosa damascena Mill. extract, Lacticaseibacillus casei, Bifidobacterium longum, Chitosan Introduction Rosa damascena Mill., a member of the genus Rosa (Rosaceae), comprises more than 200 species worldwide. This species is extensively cultivated not only as an ornamental plant but also as a valuable source of raw materials for cosmetic and pharmaceutical industries due to its characteristic aroma and diverse bioactive compounds, including tannins, flavonoids, terpenes, polyphenols, carotenoids, phenylethyl alcohol and vitamins B, C, E and K. Of these constituents, anthocyanins (a major flavonoid pigments in red rose petals) demonstrates strong antioxidant activity, lessening oxidative stress, enhancing immune defense and providing additional biological benefits such as anti-inflammatory, antidiabetic, anticancer, cardiopro-tective and neuroprotective effects [1-2]. Anthocyanins can alter gut microbiota composition by promoting the growth of beneficial bacteria such as Bifidobacteria and Lacticaseibacillus, which are essential for maintaining gut barrier health. [1, 3]. Anthocyanins modulate the expression of tight junction proteins such as occludin, claudin and ZO-1, which are essential for forming and maintaining intestinal epithelial barrier integrity. Tight junctions act as selective barriers that restrict paracellular permeability to harmful molecules andregulation of these proteins by anthocyanins enhances preservation of intestinal barrier function [1, 3]. Lacticaseibacillus casei is addressed for its resilience in acidic environments such as the stomach and intestines and its ability to produce lactic acid, which inhibits the growth of pathogenic bacteria in the gut. The L. casei has demonstrated positive effects in enhancing intestinal function, reliving gastrointestinal (GI) symptoms and decreasing inflammation within the digestive system. Additionally, research shows that L. casei can improve muscle strength and physical function in animal models and help lessening oxidative stress; thereby, promoting overall health [4]. Bifidobacterium longum provides anti-inflammatory and antioxidant benefits that decreasing liver lipid accumulation and improve muscle and cognitive functions in aging animal models. The B. longum has been shown to enhance intestinal barrier function and improve the gut microbiota composition [5]. The L. casei and B. longum demonstrate immunomodulatory effects by enhancing the body immune response to infections. In studies on Plasmodium infection, B. longum was detected effective in decreasing parasitemia and inflammation, indicating its capability to strengthen immune defense by modulating gut immune responses [5-6]. The L. casei and B. longum can lessendysbiosis or gut microbiota imbalances caused by infections. The bioactive components of R. damascena and probiotic functions of L. casei and B. longum present promising ways for improving overall health, specifically through enhanced antioxidant activity, immune response and gut microbiota balance, making them valuable for therapeutic uses. Microencapsulation is a process that involves coating a compound or particle to form microcapsules. This microencapsulation concept enables the separation of compounds and probiotic cells from their environment through a protective layer. The characteristics of this protective system are designed to safeguard the cell core and release it in a controlled manner under specific conditions, while allowing the transport of small molecules through the membrane [7]. Chitosan is effective as a coating agent due to its advantages, including non-toxicity, appropriateness for drug delivery, biodegradability and biocompatibility. Chitosan is a natural linear biopolyamino sugar derived through the deacetylation of chitin, with a non-linear chain formula (C₆H₁₁NO₄)n that is odorless and white[8]. Chitosan microencapsulation of R. damascena has successfully been carried out, demonstrating its efficacy in preserving flower quality and extending shelf life, offering a sustainable and effective approach for postharvest storage in commercial uses [9]. Studies have shown that probiotic bacteria can survive after being encapsulated with chitosan. This is because encapsulation efficiency significantly increases with higher concentrations of the biopolymer [10]. The survival rate of chitosan-encapsulated probiotics is high after incubation at low pH, although the population decreases slightly. The decrease in bacterial count during gastric acid simulation is attributed to the highly acidic stomach pH, which affects the strength of the sodium alginate-chitosan polymer as a matrix for encapsulating lactic acid bacteria (LAB) [11]. Moreover, microencap-sulation techniques, particularly those using chitosan, provide promising ways for enhancing the stability and bioavailability of these probiotics in GI environments; thereby, improving their therapeutic potentials. Microen-capsulation of R. damascena Mill. and probiotics (L. casei and B. longum) (MERP) underscores the value of R. damascena bioactives and probiotic encapsulation in preventive and therapeutic uses for managing oxidative stress, inflammation and gut health. The research identified several key gaps in the existing literature. Previous studies have largely focused on the antioxidant and anti-inflammatory characteristics of R. damascena Mill. and the probiotic benefits of L. casei and B. longum individually. However, a limited attention has been paid to synergizing these bioactives and probiotics within a stable microencapsulation system to enhance their bioavailability. The present findings, however, provided additional insight and might serve as a valuable reference for further development of a chitosan-sodium tripolyphos-phate (STPP) microencapsulation system for the synergistic co-encapsulation of R. damascena Mill. bioactives (anthocyanins and flavonoids) and probiotics (L. casei and B. longum). Combining antioxidant-rich rose extracts with probiotics in a robust encapsulation matrix, this study uniquely linked further nutraceutical uses with gut health and inflammation management, highlighting its potentials for advancing targeted delivery in the functional food system. Materials and Methods Chitosan was purchased from Merck (Germany). Solvents, including distilled water used as a solvent obtain from Brataco (Indonesia) and ethanol used as a co-solvent, obtained from Merck (Germany). All other chemicals and solvents used in this study were of analytical grade. The procedures for Rosa damascena extraction, probiotic culturing, and microencapsulation using the chitosan–STPP system are illustrated in Figure 1. 2.1. Probiotic Isolation Stage The L. casei and B. longum were purchased from the Food and Nutritional Culture Collection (FNCC), Gadjah Mada University, Indonesia. Colonies were sampled using sterile inoculation needle and each bacterium was inoculated into De Man, Rogosa, and Sharpe (MRS broth). The cultures were then incubated at 37 °C for 24 h. After incubation, their optical density and colony counts were recorded using spectrophotometer (Thermoscientific, USA). Gram staining was carried out to ensure purity of the bacteria [5]. 2.2. Red Rose Extraction Stage Rose petals were extracted using 70% ethanol pro analis (Merck, Germany) and aliquoted 1:1 [12]. The extract was then filtered through filter paper or a vacuum filtration system to separate the solid from the liquid. The extract was evaporated using rotary evaporator (Materia Medica Batu, Indonesia). The resulting liquid extract was collected using sterile glass bottle. The extract was freeze-dried (Martin Christ, Germany). 2.3. Microencapsulation Preparation The Microencapsulation was carried out using chitosan-STPP matrix. The stages of MERP formulat

Schlagwörter

Rosa damascenaLactobacillus caseiBifidobacterium longumprobioticsanthocyaninsbioaccessibilityprobiotic viabilitygastrointestinal tract simulationfunctional food deliverynutraceuticals

Zitieren

APA

Kinanti, R. G., Asiyah, R., Ramadhani, D. N., Ratna, A. P., Lestari, S. R., Hengpratom, T., & Saati, E. A. (2025). Characterization of the Chitosan Microencapsulation of Rosa damascena Mill. Extract and (Lacticaseibacillus casei and Bifidobacterium longum) Probiotics. Applied food biotechnology. https://doi.org/10.22037/afb.v12i1.46674

Vancouver

Kinanti RG, Asiyah R, Ramadhani DN, Ratna AP, Lestari SR, Hengpratom T, et al. Characterization of the Chitosan Microencapsulation of Rosa damascena Mill. Extract and (Lacticaseibacillus casei and Bifidobacterium longum) Probiotics. Applied food biotechnology. 2025. doi:10.22037/afb.v12i1.46674

BibTeX
@article{Kinanti2025,
  author = {Kinanti, Rias Gesang and Asiyah, Rokhmatul and Ramadhani, Dimas Nur and Ratna, Ardhiyanti Puspita and Lestari, Sri Rahayu and Hengpratom, Tanaporn and Saati, Elfi Anis},
  title = {Characterization of the Chitosan Microencapsulation of Rosa damascena Mill. Extract and (Lacticaseibacillus casei and Bifidobacterium longum) Probiotics},
  journal = {Applied food biotechnology},
  year = {2025},
  doi = {10.22037/afb.v12i1.46674}
}
Kostenlos starten →